Publication date: Sep 24, 2024
Evidence is limited about healthcare cost disparities associated with homelessness, particularly in recent years after major policy and resource changes affecting people experiencing homelessness occurred after the onset of the COVID-19 pandemic. We estimated 1-year healthcare expenditures, overall and by type of service, among a representative sample of people experiencing homelessness in Toronto, Canada, in 2021 and 2022, and compared these to costs among matched housed and low-income housed individuals. Data from individuals experiencing homelessness participating in the Ku-gaa-gii pimitizi-win cohort study were linked with Ontario health administrative databases. Participants (n = 640) were matched 1:5 by age, sex-assigned-at-birth and index month to presumed housed individuals (n = 3,200) and to low-income presumed housed individuals (n = 3,200). Groups were followed over 1 year to ascertain healthcare expenditures, overall and by healthcare type. Generalized linear models were used to assess unadjusted and adjusted mean cost ratios between groups. Average 1-year costs were $12,209 (95% CI $9,762-$14,656) among participants experiencing homelessness compared to $1,769 ($1,453-$2,085) and $1,912 ($1,510-$2,314) among housed and low-income housed individuals. Participants experiencing homelessness had nearly seven times (6. 90 [95% confidence interval [CI] 5. 98-7. 97]) the unadjusted mean ratio (MR) of costs as compared to housed persons. After adjustment for number of comorbidities and history of healthcare for mental health and substance use disorders, participants experiencing homelessness had nearly six times (adjusted MR 5. 79 [95% CI 4. 13-8. 12]) the expected healthcare costs of housed individuals. The two housed groups had similar costs. Homelessness is associated with substantial excess healthcare costs. Programs to quickly resolve and prevent cases of homelessness are likely to better meet the health and healthcare needs of this population while being a more efficient use of public resources.
Open Access PDF
Semantics
Type | Source | Name |
---|---|---|
disease | MESH | COVID-19 pandemic |
disease | IDO | history |
disease | MESH | substance use disorders |
drug | DRUGBANK | Tropicamide |
pathway | REACTOME | Reproduction |
disease | MESH | housing instability |
disease | MESH | infection |
disease | MESH | privacy |
disease | MESH | Asthma |
pathway | KEGG | Asthma |
disease | MESH | Congestive Heart Failure |
drug | DRUGBANK | Ranitidine |
disease | MESH | death |
disease | MESH | comorbidity |
disease | MESH | emergency |
disease | IDO | algorithm |
drug | DRUGBANK | Serine |
disease | MESH | lung disease |
disease | MESH | heart disease |
disease | MESH | stroke |
disease | MESH | chronic kidney disease |
disease | MESH | liver disease |
disease | MESH | AIDS |
disease | MESH | psychotic disorders |
disease | MESH | anxiety |
disease | MESH | obsessive compulsive disorder |
disease | MESH | personality disorders |
disease | MESH | neurological disorder |
drug | DRUGBANK | Coenzyme M |
disease | MESH | Hypertension |